unknown
Stage
2
Investors
About
Hesperos develops human-on-a-chip multi-organ in vitro platforms designed to model human physiology and disease for drug discovery, safety testing, and therapeutic development, reducing reliance on animal testing.
Explore Hesperos's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.